Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Blood Advances|October 9, 2021
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AMLJuliette Lambert, Jerome Lambert, Xavier Thomas, et al.
JACC. Advances|October 22, 2025
Impact of Exercise on Clonal HematopoiesisJessica M Scott, Brandon L Tsai, Caitlin Stewart, et al.
Haematologica|July 9, 2013
The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrestRaouf Ben Abdelali, Vahid Asnafi, Arnaud Petit, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Impact of COVID-19 on healthcare organisation and cancer outcomesAurelie Bardet, Alderic M Fraslin, Jamila Marghadi, et al.
Blood|March 17, 2016
Comprehensive mutational profiling of core binding factor acute myeloid leukemiaNicolas Duployez, Alice Marceau-Renaut, Nicolas Boissel, et al.
Hemasphere|August 23, 2021
Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast CancersSabine Khalife-Hachem, Khalil Saleh, Florence Pasquier, et al.
JCO Precision Oncology|May 30, 2024
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING TrialJulieta Rodriguez, Capucine Baldini, Arnaud Bayle, et al.
Science Translational Medicine|September 24, 2025
CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesisMyriam Ben Khelil, Ahmadreza Arbab, Janesa Srikanthan, et al.
Gut Microbes|September 7, 2020
Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengtheningThomas Hueso, Kenneth Ekpe, Camille Mayeur, et al.
Blood Advances|February 11, 2021
Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohortEdmond Chiche, Ramy Rahmé, Sarah Bertoli, et al.
Pageof 7